Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

ClinicalTrials.gov ID: NCT07214779

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT07214779. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 15, 2026, 2:27 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Open-Label Study of INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate INCB123667 versus investigator's choice of chemotherapy in participants with platinum-resistant ovarian cancer with cyclin E1 overexpression.

Study identification

NCT ID: NCT07214779
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 3
Lead sponsor: Incyte Corporation; Industry
Enrollment: 466 participants

Conditions and interventions

Conditions

Ovarian Cancer

Interventions

INCB123667 Drug
Investigator's choice of chemotherapy Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: Female
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Dec 9, 2025 (Actual)
Primary completion: Nov 15, 2028 (Estimated)
Completion: May 14, 2029 (Estimated)
Last update posted: Oct 15, 2026

2025 – 2029

United States locations

U.S. sites: 63
U.S. states: 28
U.S. cities: 59

Facility	City	State	ZIP	Site status
Alaska Womens Cancer Care Akwcc	Anchorage	Alaska	99508	Completed
University of Arizona Cancer Center	Tucson	Arizona	85724-5002	Completed
City of Hope Medical Center	Duarte	California	91010	Recruiting
Providence Medical Foundation	Fullerton	California	92835	Completed
University of California, San Diego-Moores Cancer Center	La Jolla	California	92037	Completed
Valkyrie Clinical Trials	Los Angeles	California	90067	Recruiting
Uci Health Chao Family Comprehensive Cancer Center	Orange	California	92868-3298	Completed
Ventura County Hematology Oncology Specialists-Oxnard	Oxnard	California	93030	Completed
University of Colorado Cancer Center	Aurora	Colorado	80045	Completed
Mount Sinai Medical Center Comprehensive Cancer Center	Miami Beach	Florida	33140	Not yet recruiting
Brcr Global	Miramar	Florida	33027	Completed
Sarasota Memorial Health Care System	Sarasota	Florida	34239	Completed
Winship Cancer Institute At Emory University	Atlanta	Georgia	30322	Completed
Georgia Cancer Center	Augusta	Georgia	30912	Completed
The University of Chicago Medicine	Chicago	Illinois	60637	Completed
Carle Cancer Center	Effingham	Illinois	62401-2006	Completed
Northshore University Health System-Evanston Hospital	Evanston	Illinois	60201	Completed
City of Hope - Chicago Cancer Center	Zion	Illinois	60099	Completed
St Elizabeth Healthcare	Edgewood	Kentucky	41017	Completed
Women'S Cancer Care	Covington	Louisiana	70433	Not yet recruiting
Trials365, Llc	Shreveport	Louisiana	71103	Not yet recruiting
Maine Center For Cancer Medicine	Scarborough	Maine	04074	Completed
Holy Cross Hospital	Silver Spring	Maryland	20910	Completed
Greater Baltimore Medical Center	Towson	Maryland	21204	Not yet recruiting
Henry Ford Cancer - Detroit	Detroit	Michigan	48202	Completed
Mercy Hospital St. Louis - David C. Pratt Cancer Center	St Louis	Missouri	63141	Completed
Billings Clinic	Billings	Montana	59101	Recruiting
Women'S Cancer Center of Nevada	Las Vegas	Nevada	89106	Completed
Center of Hope	Reno	Nevada	89511	Completed
Maimonides Medical Center	Short Hills	New Jersey	07078	Not yet recruiting
Unm Comprehensive Cancer Center	Albuquerque	New Mexico	87131	Completed
Levine Cancer Center	Charlotte	North Carolina	28204	Not yet recruiting
Novant Presbyterian Hospital	Charlotte	North Carolina	28204	Recruiting
East Carolina University	Greenville	North Carolina	27834	Completed
Novant Health Oncology Specialists	Winston-Salem	North Carolina	27103	Recruiting
Atrium Health Wake Forest Baptist	Winston-Salem	North Carolina	27157	Not yet recruiting
Cleveland Clinic Foundation	Cleveland	Ohio	44195-0001	Completed
Ohio Health Research Institute	Columbus	Ohio	43214	Completed
Miami Valley Hospital South	Dayton	Ohio	45459	Completed
Promedica Flower Hospital	Sylvania	Ohio	43560	Completed
Oncology Associates of Oregon, P.C.	Eugene	Oregon	97401	Recruiting
Providence Cancer Institute Franz Clinic	Portland	Oregon	97213	Recruiting
Penn State Milton S. Hershey Medical Center	Hershey	Pennsylvania	17033	Not yet recruiting
University of Pittsburgh Cancer Institute Cancer Services	Pittsburgh	Pennsylvania	15213	Recruiting
Allegheny Health Network- West Penn Hospital	Pittsburgh	Pennsylvania	15224	Completed
Lankenau Medical Center	Wynnewood	Pennsylvania	19096	Completed
Wellspan Gynecologic Oncology	York	Pennsylvania	17403	Completed
Sanford Cancer Center-Sioux Falls	Sioux Falls	South Dakota	57104-8805	Recruiting
Erlanger Health, Inc.	Chattanooga	Tennessee	37403	Recruiting
Texas Oncology-Abilene	Abilene	Texas	79606	Recruiting
Texas Oncology Cancer Center	Austin	Texas	78731	Not yet recruiting
Jps Health Network	Fort Worth	Texas	76104	Completed
The University of Texas Health Science Center Houston	Houston	Texas	77030	Completed
The University of Texas-Md Anderson Cancer Center	Houston	Texas	77030	Completed
Texas Oncology, P.A., San Antonio Medical Center - Uso	San Antonio	Texas	78240	Not yet recruiting
Texas Oncology Cancer Center	Sugar Land	Texas	77479	Recruiting
Texas Oncology (Txo) Northeast Texas (Tyler)	Tyler	Texas	75702	Not yet recruiting
University of Virginia Health System	Charlottesville	Virginia	22908	Completed
Inova Schar Cancer Institute	Fairfax	Virginia	22031	Completed
Fred Hutchinson Cancer Center	Seattle	Washington	98109	Completed
Providence Sacred Heart Medical Center and Children'S Hospital	Spokane	Washington	99204	Not yet recruiting
West Virginia University	Morgantown	West Virginia	26505	Completed
Prohealth Care	Waukesha	Wisconsin	53188	Completed

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 135 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07214779, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Oct 15, 2026 · Synced Nov 15, 2026